Johnson & Johnson
Recent News About Johnson & Johnson
-
Johnson & Johnson highlights unmet needs in maternal fetal immunology at ISUOG Congress
Johnson & Johnson has announced that six abstracts, including an oral poster presentation, will be presented at the 35th International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) World Congress in Cancún, Mexico.
-
Johnson & Johnson schedules Q3 investor call for October 14
Johnson & Johnson announced it will hold an investor conference call on Tuesday, October 14, at 8:30 a.m. Eastern Time to discuss its third-quarter financial results.
-
Johnson & Johnson presents positive results from real-world study on VARIPULSE platform
Johnson & Johnson MedTech has released new data from the VARIPURE substudy of SECURE, a real-world evaluation of its VARIPULSE Platform for pulsed field ablation (PFA) in atrial fibrillation (AF) treatment.
-
Johnson & Johnson reports long-term survival benefit for Impella CP after heart attack
New long-term data from the DanGer Shock randomized controlled trial, presented at the European Society of Cardiology Congress and published in The New England Journal of Medicine, show that routine use of the Impella CP heart pump in patients who...
-
Johnson & Johnson ends phase 2a trial of nipocalimab combo for rheumatoid arthritis
Johnson & Johnson has announced results from its Phase 2a DAISY proof-of-concept study, which evaluated the combination of nipocalimab with an anti-tumor necrosis factor alpha (anti-TNFα) therapy in patients with rheumatoid arthritis (RA) who have...
-
Johnson & Johnson invests $2 billion in North Carolina biomanufacturing expansion
Johnson & Johnson has announced a $2 billion commitment to expand its manufacturing capabilities in the United States, specifically at FUJIFILM’s new biopharmaceutical site in Holly Springs, North Carolina.